The purpose of this study was to determine the feasibility and efficacy of terminating life-threatening ventricular tachyarrhythmia by low-energy synchronous or asynchronous shocks delivered through a transesophageal catheter that had both an anode and a cathode. Forty-three episodes of ventricular fibrillation or flutter (Vf or VF) were provoked by transesophageal asynchronous random shocks occurring during the vulnerable period of the ventricular cycle in seven dogs and seven pigs that were healthy adults. The 43 episodes of Vf or VF were terminated by the transesophageal technique. The defibrillation energy thresholds were 23.11±+6.28 J (range, 5-30 J). Seven episodes of ventricular tachycardia (VT) with a cycle length of 360 msec or less (330+±27 msec) were provoked by ventricular pacing stimuli during acute myocardial ischemia resulting from delayed resuscitation in two dogs and three pigs. Five of the seven VTs had a duration of 31 seconds or more, and they were all terminated by transesophageal synchronous shocks, the cardioversion thresholds being 1.71±2.25 J (range, 0.25-5 J). Fourteen episodes of idioventricular tachycardia (IVT) with a cycle length of 400 msec or more (445+±33.5 msec) spontaneously occurred after the use of adrenaline and after defibrillation in four dogs and five pigs. We also succeeded in terminating seven episodes of IVT with a duration of 34 seconds or more by the same means of treating VT, although IVT is not an indication for cardioversion in the clinical setting. The cardioversion thresholds were 1.45+±2.2 J (range, 0.25-5 J). The difference between the mean energy levels required for cardioversion of VT and IVT were not significant (t=0.20, p>0.5). The remaining two VTs and YIVs had a duration less than 30 seconds and were not tested. There was no significant difference of threshold energy of cardioversion for VT or IVT and Vf or VF between dogs and pigs and between animals that weighed more than 12.5 kg and less than 12.5 kg. There were no apparent functional or histologic ill effects in the esophagi that received cumulative shocks of 192 ±91 J (100-377.5 J). In 246 synchronous or asynchronous shocks (including subthreshold shocks) for cardioversion, acceleration of VT or IVT or degeneration to Vf or VF never occurred. We conclude that this new procedure is a safe and effective method for treating life-threatening ventricular tachyarrhythmias. (Circulation 1989(Circulation :80:1354(Circulation -1359 In recent years, transesophageal atrial pacing has been used to diagnose and treat paroxysmal supraventricular tachycardia because it offers some advantages over transvenous cardiac pacing.1-3 However, the method fails to terminate life-threatening ventricular tachyarrhythmias. low-energy cardioversion with a transvenous electrode catheter,4-7 we reasoned that life-threatening ventricular tachyarrhythmias could be safely and effectively terminated by countershock of very low energy delivered through intraesophageal electrodes. The purpose of this study was to test this hypothesis using canine and porcine models.
The purpose of this study was to determine the feasibility and efficacy of terminating life-threatening ventricular tachyarrhythmia by low-energy synchronous or asynchronous shocks delivered through a transesophageal catheter that had both an anode and a cathode. Forty-three episodes of ventricular fibrillation or flutter (Vf or VF) were provoked by transesophageal asynchronous random shocks occurring during the vulnerable period of the ventricular cycle in seven dogs and seven pigs that were healthy adults. The 43 episodes of Vf or VF were terminated by the transesophageal technique. The defibrillation energy thresholds were 23.11±+6.28 J (range, 5-30 J). Seven episodes of ventricular tachycardia (VT) with a cycle length of 360 msec or less (330+±27 msec) were provoked by ventricular pacing stimuli during acute myocardial ischemia resulting from delayed resuscitation in two dogs and three pigs. Five of the seven VTs had a duration of 31 seconds or more, and they were all terminated by transesophageal synchronous shocks, the cardioversion thresholds being 1.71±2.25 J (range, 0.25-5 J). Fourteen episodes of idioventricular tachycardia (IVT) with a cycle length of 400 msec or more (445+±33.5 msec) spontaneously occurred after the use of adrenaline and after defibrillation in four dogs and five pigs. We also succeeded in terminating seven episodes of IVT with a duration of 34 seconds or more by the same means of treating VT, although IVT is not an indication for cardioversion in the clinical setting. The cardioversion thresholds were 1.45+±2.2 J (range, 0.25-5 J). The difference between the mean energy levels required for cardioversion of VT and IVT were not significant (t=0.20, p>0.5). The remaining two VTs and YIVs had a duration less than 30 seconds and were not tested. There was no significant difference of threshold energy of cardioversion for VT or IVT and Vf or VF between dogs and pigs and between animals that weighed more than 12.5 kg and less than 12.5 kg. There were no apparent functional or histologic ill effects in the esophagi that received cumulative shocks of 192 ±91 J (100-377.5 J). In 246 synchronous or asynchronous shocks (including subthreshold shocks) for cardioversion, acceleration of VT or IVT or degeneration to Vf Fifteen minutes after the sinus rhythm was recovered by transesophageal low-energy cardioversion, Vf or VF was repeatedly provoked by the same method in some of the animals. The energy level chosen for each attempt at cardioversion was set one step lower than that used in the previous successful cardioversion. Throughout the procedure, cardiac compression, transesophageal cardial pacing, resuscitation drugs, and so forth were administrated when necessary.
After the procedure was completed, synchronous shocks (1-60 J), which were irrelevant to cardioversion of the ventricular tachyarrhythmias, were NO JTS 135-3 71tm" ; FIGURE 2. Tracing of a random asynchronous shock that occurred about 40 msec before the peak of T wave and provoked an episode of ventricular fibrillation.
repeatedly delivered with the same method in all animals to determine the level of shock energy tolerated by the esophagus. Esophagi from dead animals and esophagi from the survivors that were killed 3-25 days later were examined by serial histologic sections.
Statistical Analysis
The Student's t test was used for statistical analysis of the results. Values are expressed as mean+ SD.
Results

Animal Model of Ventricular Tachyarrhythmias
All animals had sinus rhythm at the onset of the study. Vf or VF was provoked at least once (one to seven times) in each animal by means of transesophageal random asynchronous shock. However, we found that an episode of Vf or VF could be provoked only by the shock that occurred about 40 msec before the peak of the T wave on the ECG and only when its energy level was 10 J or more. An average of 7.2 (five to 11) random asynchronous shocks were required for each provocation of Vf or VF. Figure 2 presents a record of a successful provocation of Vf. Altogether, 43 episodes of Vf or VF were provoked, of which 22 episodes occurred in the dogs and 21 in the pigs.
Acute myocardial ischemia with a manifestation of an ST segment depression of 0.25-0.6 mV occurred in all animals after Vf or VF was provoked and terminated either once or repeatedly. During that time, the programmed ventricular pacing provoked seven episodes of VT with a cycle length of 360 msec or less (330±27 msec) in two dogs and three pigs. Two of seven episodes spontaneously terminated at 6 and 15 seconds, and were, therefore, not tested by the method; the remainder had a duration of 31 seconds or more. In five pigs and four dogs, adrenaline (1 or 2 mg i.v.) was used to transform fine Vf waves to rough Vf waves to make defibrillation easier. They had 14 spontaneous episodes of idioventricular tachycardia (IVT) with a cycle length of 400 msec or more (448+33.5 msec) after defibrillation. We also terminated seven episodes of IVT with a duration of 34 msec or more. The reason for terminating these episodes was to test the capability of transesophageal cardioversion, though IVT is not an indication for cardioversion in our clinic. The other seven episodes of IVT spontaneously terminated within 30 seconds.
Efficacy
Altogether, 43 episodes of Vf or VF were successfully terminated by the transesophageal technique. The energy levels associated with successful defibrillation varied from 5 to 30 J (23.1+6.28 J). Figure 3 shows the record of a successful transesophageal defibrillation; five episodes of VT were terminated by this method. The energy levels associated with successful cardioversion ranged from 0.25 to 5 J (1.71±+2.25 J). Figure 4 shows the record of a successful cardioversion for VT. The energy required for terminating seven episodes of IVT ranged from 0.25 to 5 J (1.45+2.2 J). els required for cardioversion of VT and IVT was not significant (t=0.20, p>0.5). Thus, we terminated 12 episodes of VT or IVT with a duration between 31 and 146 seconds. There was no significant difference between the threshold energy of cardioversion for VT or IVT and Vf or VF in treating pigs and dogs and between animals that weighed more than 12.5 kg and less than 12.5 kg (see Tables 1 and 2 ).
Safety
All animals received cumulative shock energy ranging from 100 to 377.5 J (192±91 J), including shock energy of subthreshold attempts and energy that was irrelevant to cardioversion. There were no apparent histologic effects in their esophagi according to microscopy. Six surviving animals were observed for 3-25 days and were then killed. There was no occurrence of anorexia, hiccup, or symptoms of esophagospasm during the observation period. In 246 synchronous or asynchronous shocks for cardioversion (including subthreshold shocks), acceleration of the VT or IVT or degeneration to Vf or VF never occurred. Three hundred ten random asynchronous shocks that failed to provoke Vf or VF, and also, 213 synchronous shocks irrelevant to cardioversion of the ventricular tachyarrhythmias never induced unwanted arrhythmias.
Discussion
Conventional transthoracic cardioversion is accepted as the most effective and safest form of electrical therapy to terminate life-threatening tachyarrhythmias. However, it has obvious limitations for long-term applications. The purpose of this study was to develop a therapeutic approach that may be as safe and effective as transthoracic cardioversion but that could have some advantages over the conventional method. During countershock by the usual surface electrode technique, only a fraction of the energy administered to the patient is usefully consumed within the heart; the greater part of the administered energy is expended in extracardiac tissues where it is wasted because such tissue does not participate in depolarizing the heart. The transesophageal method, as does the transvenous method, allows the electrodes to be placed closer to the heart.5-9 Thus, this method can entirely depolarize the heart with fairly low energy.
In 1966, McNally et a110 placed one electrode that consisted of bars (22-gauge, 7 cm long coil) in the esophagus, and the other electrode was placed on the precordium of eight anesthetized and five unanesthetized patients. With this method, cardioversion energy for atrial fibrillation was reduced to less than half of that when the conventional surface electrode placement was used. Thirteen patients were observed carefully for any symptoms suggestive of esophageal injury or dysfunction. No symptoms occurred, either immediately or within 4 months. The cardioversion energy for ventricular tachyarrhythmias was not researched by McNally et al, and we did not compare the energy requirement of their esophageal technique with that of our technique. However, we are certain that our method has a lower energy requirement than that of McNally et al because the energy was delivered in such a way that it avoided extracardiac tissues.
The present study is the first attempt to place both the anode and the cathode in the esophagus of animals, and it shows that transesophageal cardioversion with small amounts of energy can safely and effectively terminate life-threatening tachyarrhythmias. In animals, the energy levels of successful FIGURE 5. Tracing of a synchronous shock of 0.5 J that terminated idioventricular tachycardia. 
